Bridgeway Capital Management »

Relmada Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $910k 196k 4.65
2023-09-30 $306k 102k 3.00
2023-06-30 $191k 78k 2.46
2023-03-31 $74k 33k 2.26